Role of N-Cadherin in Pancreatic Tumor Microenvironment
N-钙粘蛋白在胰腺肿瘤微环境中的作用
基本信息
- 批准号:8555506
- 负责人:
- 金额:$ 17.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-26 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdenocarcinomaAdenocarcinoma CellBenignBiologicalCadherinsCell CommunicationCellsClinical ResearchCollagenDepositionDiseaseDistantEnvironmentEpithelial CellsEvolutionGeneticGenetically Engineered MouseGoalsGrowthHumanIn VitroIndividualKnock-outMalignant NeoplasmsMalignant neoplasm of pancreasMediatingMesenchymalModelingMolecularN-CadherinNeoplasm MetastasisOrganPancreasPancreatic AdenocarcinomaRelative (related person)RoleSignal TransductionStagingStromal CellsStromal NeoplasmTestingTissuesTumor Cell InvasionUp-RegulationWorkXenograft Modelbasecancer invasivenesscell behaviorcell motilityepithelial to mesenchymal transitionimplantationmacrophagemouse modelneoplastic cellpancreatic neoplasmstellate celltumortumor progressiontumorigenesis
项目摘要
Pancreafic adenocarcinomas are characterized by extensive deposition of collagen 1, which can have profound
effects on cell behavior. We have shown that cells derived from pancreatic adenocarcinomas respond In vitro
to exogenous collagen I by transforming from a non-motile epithelial cell to a highly motile and invasive
mesenchymal cell. A hallmark of epithelial to mesenchymal transition is an increase in expression of the
mesenchymal cadherin, N-cadherin. Keith's lab has been studying the role of N-cadherin in tumor progression
for more than a decade, and we have convincingly demonstrated that upregulafion of N-cadherin expression
converts epithelial cells from benign, non-mofile, non-invasive cells to highly mofile and invasive cells. From these studies, we hypothesized that N-cadherin promotes tumor cell invasion. Clinical studies from our lab and
others have validated our hypothesis. Of particular significance to the current proposal is the fact that Ncadherin
is expressed by more than 50% of invasive pancreatic tumors.
Here, long-temn goal is to determine the molecular basis of N-cadherin-mediated invasiveness and metastasis
in PC. Previous studies from our lab have demonstrated that N-cadherin knockdown in BxPC3 and Capani
pancreatic adenocarcinoma cells can significantly decrease tumor progression and metastasis in orthotopic
xenograft models. However, the role of individual components of the tumor microenvironment is not cleariy
understood. Genetically engineered mouse models have been shown to faithfully mimic the genefic and
biological evolufion of their human counterpart diseases. The hypothesis is that N-cadherin expression In
multiple components of tumor microenvironment is critical for PC metastasis. We propose to test the
hypothesis by generafing and ufilizing syngeneic tumor implantafion models with alterafions in N-cadherin
expression in individual components of PC microenvironment.
In addition to the critical role of N-cadherin expression in pancreafic adenocarcinoma cells in promoting cancer
and metastasis, N-cadherin is also expressed and involved in the mofility of stellate cells as well as
macrophages. Both, pancreafic stellate cells and macrophages have been shown to facilitate tumorigenesis
and invasiveness of pancreatic adenocarcinoma cells. Thus, we further hypothesize that N-cadherin
expression on pancreatic stellate cells and macrophages facilitates PC progression and invasion.
Hence, we propose to test the relative contribufion of N-cadherin expression on stellate cells and macrophages
toward PC progression and invasion by proposing the following specific aims:
Aim 1: To determine the contribufion of N-cadherin-mediated adenocarcinoma cell-stromal cell interacfions in
PC. Our working hypothesis of this aim is that N-cadherin mediates tumor-stromal interactions and N-cadherin
expression on stromal cells facilitates their tumor recruitment.
Aim 2: To determine the contribufion of N-cadherin-mediated adenocarcinoma cell-macrophage interacfions
toward PC invasiveness. Our working hypothesis of this aim is that N-cadherin expression on macrophages
facilitates their recruitment and acfivafion in the tumor cell compartments and facilitates PC progression.
胰腺癌的特点是胶原蛋白 1 广泛沉积,这可能对胰腺癌产生深远的影响。
对细胞行为的影响。我们已经证明源自胰腺腺癌的细胞在体外有反应
通过从非活动性上皮细胞转变为高度活动性和侵袭性的外源性胶原蛋白 I
间充质细胞。上皮细胞向间质细胞转化的一个标志是
间质钙粘蛋白,N-钙粘蛋白。 Keith 的实验室一直在研究 N-钙粘蛋白在肿瘤进展中的作用
十多年来,我们令人信服地证明了 N-钙粘蛋白表达的上调
将上皮细胞从良性、非运动性、非侵袭性细胞转化为高度运动性和侵袭性细胞。从这些研究中,我们假设 N-钙粘蛋白促进肿瘤细胞侵袭。我们实验室的临床研究和
其他人验证了我们的假设。对当前提案特别重要的是 Ncadherin
超过 50% 的侵袭性胰腺肿瘤表达。
这里的长期目标是确定 N-钙粘蛋白介导的侵袭和转移的分子基础
在电脑中。我们实验室之前的研究表明,BxPC3 和 Capani 中的 N-钙粘蛋白敲低
胰腺腺癌细胞可以显着降低原位肿瘤进展和转移
异种移植模型。然而,肿瘤微环境的各个组成部分的作用尚不清楚。
明白了。基因工程小鼠模型已被证明能够忠实地模仿基因和
人类对应疾病的生物进化。假设 N-钙粘蛋白表达
肿瘤微环境的多种成分对于 PC 转移至关重要。我们建议测试
通过生成和利用 N-钙粘蛋白改变的同基因肿瘤植入模型来提出假设
PC 微环境的各个组成部分中的表达。
胰腺癌细胞中 N-钙粘蛋白表达除了在促进癌症发生方面发挥关键作用外
N-钙粘蛋白也表达并参与星状细胞的运动以及转移
巨噬细胞。胰腺星状细胞和巨噬细胞均已被证明可促进肿瘤发生
和胰腺癌细胞的侵袭性。因此,我们进一步假设 N-钙粘蛋白
胰腺星状细胞和巨噬细胞上的表达促进 PC 进展和侵袭。
因此,我们建议测试 N-钙粘蛋白表达对星状细胞和巨噬细胞的相对贡献
通过提出以下具体目标来实现 PC 的进展和入侵:
目标 1:确定 N-钙粘蛋白介导的腺癌细胞-基质细胞相互作用在
个人电脑。我们对此目标的工作假设是 N-钙粘蛋白介导肿瘤-基质相互作用,并且 N-钙粘蛋白
基质细胞上的表达促进它们的肿瘤募集。
目标 2:确定 N-钙粘蛋白介导的腺癌细胞-巨噬细胞相互作用的贡献
走向 PC 入侵。我们对此目标的工作假设是巨噬细胞上的 N-钙粘蛋白表达
促进它们在肿瘤细胞区室中的募集和激活,并促进 PC 进展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KEITH R JOHNSON其他文献
KEITH R JOHNSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KEITH R JOHNSON', 18)}}的其他基金
COBRE: UNE MED CTR: ADMINISTRATIVE CORE
COBRE:UNE MED CTR:行政核心
- 批准号:
8360438 - 财政年份:2011
- 资助金额:
$ 17.24万 - 项目类别:
P-2: Inhibitors of N-cahedrin in the treatment of pancreatic cancer
P-2:N-caedrin 抑制剂治疗胰腺癌
- 批准号:
8328170 - 财政年份:2011
- 资助金额:
$ 17.24万 - 项目类别:
COBRE: UNE MED CTR: ADMINISTRATIVE CORE
COBRE:UNE MED CTR:行政核心
- 批准号:
8168384 - 财政年份:2010
- 资助金额:
$ 17.24万 - 项目类别:
Exploiting Novel Pathways to Treat Pancreatic Cancer
探索治疗胰腺癌的新途径
- 批准号:
7571462 - 财政年份:2009
- 资助金额:
$ 17.24万 - 项目类别:
相似国自然基金
HJURP调控PRDX1增加雄激素受体蛋白稳定性导致前列腺癌细胞对恩扎卢胺耐药的机制
- 批准号:82373188
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
抑制MRPS21协同Bcl-xL抑制剂诱导前列腺癌细胞合成致死的分子机制研究
- 批准号:82303033
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肝细胞源MIF招募CD74+胰腺癌细胞介导非酒精性脂肪肝(NAFLD)驱动的胰腺癌肝转移的机制研究
- 批准号:82303933
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
HA依赖的糖被调节乳腺癌细胞膜张力对细胞干性化影响的机制研究
- 批准号:82372710
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
LncRNA-DKFZP434K028调控HNRNPA2B1影响乳腺癌细胞外泌体miR-939的包装和释放促进肿瘤相关巨噬细胞M2极化的分子机制研究
- 批准号:82373043
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Modeling Neoplastic Progression in Barrett's Esophagus - Renewal -2
巴雷特食管肿瘤进展建模 - 更新 -2
- 批准号:
10594704 - 财政年份:2023
- 资助金额:
$ 17.24万 - 项目类别:
Precancer Atlas of Familial Adenomatous Polyposis
家族性腺瘤性息肉病癌前图谱
- 批准号:
10820046 - 财政年份:2023
- 资助金额:
$ 17.24万 - 项目类别:
Identify the target proteins of one ADC-specific and two SCC-specific pfeRNAs and investigate the mechanisms underlying the pfeRNA-protein interaction.
鉴定一种 ADC 特异性 pfeRNA 和两种 SCC 特异性 pfeRNA 的靶蛋白,并研究 pfeRNA-蛋白质相互作用的机制。
- 批准号:
10579497 - 财政年份:2023
- 资助金额:
$ 17.24万 - 项目类别:
SEMIColon: Somatic Exploration of Mosaicism in Colon
SEMIColon:结肠镶嵌现象的体细胞探索
- 批准号:
10751575 - 财政年份:2023
- 资助金额:
$ 17.24万 - 项目类别: